96745 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links Kallidins; Bradykinins; Related peptides
METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN
#2PEPTIDE-DRUG CONJUGATES
#3A METHOD FOR PRODUCTION OF HIGH PURITY ICATIBANT
#4Therapeutic fusion proteins
#5Kinin-based theranostic probes for solid cancers and uses thereof
#6Nucleic acids encoding antibodies to Kallidin and des-Arg-Kallidin and host cells comprising the same
#7Compositions and methods for use in diagnosis of alzheimer's disease
#8Methods for treating pain using antibodies to Kallidin and des-Arg-Kallidin
#9Bradykinin receptor modulators and use thereof
#10Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders
#11Antibodies to kallidin and des-Arg-kallidin
#12Therapeutic fusion proteins
#13Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
#14Peptides, compositions and uses thereof
#15N-Terminal Dimerization Methods with Bis-Amindino Acid and Bis-Thioimidate Derivatives
#16KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF
#17NEO-TRYPTOPHAN
#18Methods for preventing and treating angioedema
#19COMPOSITIONS AND METHODS FOR ENHANCING CELLULAR TRANSPORT OF BIOMOLECULES
#20Healthy kidney biomarkers
#21NEO-TRYPTOPHAN
#22Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma
#23Peptides, compositions and uses thereof
#24NEO-TRYPTOPHAN
#25LC/MS Blends Containing Ionizing Additives
#26Antagonists of the bradykinin B1 receptor
#27Antagonists of the bradykinin B1 receptor
#28Anti-cancer compounds
#29Kinin Breceptor peptide agonists and uses thereof
#30Antagonists of the bradykinin B1 receptor
#31Peptidic And Peptidoid Bradykinin B1 Receptor Antagonists And Uses Thereof
#32Bradykinin Breceptor antagonist peptide from amphibian skin
#33Neo-tryptophan
#34Methods for the production of peptide derivatives
#35Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
#36Anti-cancer compounds
#37Using amines or amino acids as mobile phase modifiers in chromatography
#38Neo-tryptophan
#39Antagonists of the brandykinin B1 receptor
#40Octapeptide bombesin analogs